EGFR and non-small cell lung carcinoma: Accordingly, we conducted a retrospective study to compare the efficacy and clinical outcomes of treatment with ICIs alone and with ICIs in combination with chemotherapy in patients with metastatic EGFR-mutant NSCLC.